Traumatic brain injury (TBI) occurs when external forces impact the brain. TBIs are a consequence of motor vehicle accidents, injuries sustained in contact sports, or experiences encountered by combat veterans. Current medical treatment of TBI primarily focuses on alleviating symptoms rather than addressing the root cause of the injury and long-term effects. One emerging hypothesis is that aspects of long-term TBI symptoms may trace back to neuro-immune response following injury. The goal of this project is to develop functionalized nanoliposomes loaded with a membrane-impermeant toxin, chlodronate, such that they can be used to deplete the activated microglial we hypothesize are at the root of some long-term TBI symptoms. Here, we develop chlodronate loaded liposomes with surface-exposed, carboxylic acid-terminated, PEG-2000 spacers. These allow coupling of proteins, such as antibodies targeting specific receptors on our target microglial population, using EDC/NHS chemistry. The formulation was successful, resulting in a multimodal LNP-conjugated system, with future studies planned in rats to evaluate targeting efficiency.
Metrics
1 Record Views
Details
Title
Developing functional lipid nanoparticles for depletion of microglia following traumatic brain injury
Creators
Jarelis Nilda Cabrera
Contributors
Shae B. Padrick (Advisor)
Ramesh Raghupathi (Advisor)
Awarding Institution
Drexel University
Degree Awarded
Master of Science (M.S.)
Publisher
Drexel University
Number of pages
ix, 56 pages
Resource Type
Thesis
Language
English
Academic Unit
College of Medicine; Drexel University
Other Identifier
991022154673404721
Research Home Page
Browse by research and academic units
Learn about the ETD submission process at Drexel
Learn about the Libraries’ research data management services